25
42
Growth Score 25 in past quarter
-3 pts
Heat Score 42 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
MPM Capital is a biotechnology investment firm that invests in companies to develop therapeutic technologies in oncology.
Briggs Morrison: Managing DirectorPast Role: Syndax Pharmaceuticals, President, Head of Research & Development
Elizabeth Stoner: Entrepreneur Partner
About the Company
MPM Capital is a healthcare investment firm that invests in companies developing therapeutic technologies in oncology. The company invests in life sciences companies that seek to cure diseases by translating science into clinical outcomes. The company prefers to invest in the biotechnology, healthcare, and life sciences sectors.